Methodology comparison between pyrosequencing and Sanger sequencing assay in detecting CYP2C19*17 polymorphism

WANG Qian, DU Ya-Mei, ZHANG Guo-Jun, KANG Xi-Xiong

Chinese Medicinal Biotechnology ›› 2014, Vol. 9 ›› Issue (3) : 222-224.

PDF(298 KB)
Chinese Medicinal Biotechnology
PDF(298 KB)
Chinese Medicinal Biotechnology ›› 2014, Vol. 9 ›› Issue (3) : 222-224. DOI: 10.3969/cmba.j.issn.1673-713X.2014.03.012

Methodology comparison between pyrosequencing and Sanger sequencing assay in detecting CYP2C19*17 polymorphism

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2014, 9(3): 222-224 https://doi.org/10.3969/cmba.j.issn.1673-713X.2014.03.012

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(298 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉